These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 34467)

  • 21. NMDA receptor losses in putamen from patients with Huntington's disease.
    Young AB; Greenamyre JT; Hollingsworth Z; Albin R; D'Amato C; Shoulson I; Penney JB
    Science; 1988 Aug; 241(4868):981-3. PubMed ID: 2841762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GABA receptor binding and endogenous inhibitors in normal human brain and Huntington's disease.
    Olsen RW; Van Ness P; Napias C; Bergman M; Tourtellotte WW
    Adv Biochem Psychopharmacol; 1980; 21():451-60. PubMed ID: 6246754
    [No Abstract]   [Full Text] [Related]  

  • 23. [3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia.
    Schoemaker H; Morelli M; Deshmukh P; Yamamura HI
    Brain Res; 1982 Sep; 248(2):396-401. PubMed ID: 6291702
    [No Abstract]   [Full Text] [Related]  

  • 24. High affinity inhibition of [3H]-flunitrazepam binding to brain benzodiazepine receptors by CGS 9896, a novel pyrazoloquinoline.
    Gee KW; Horst WD; O'Brien R; Yamamura HI
    Biochem Biophys Res Commun; 1982 Mar; 105(2):457-61. PubMed ID: 6124246
    [No Abstract]   [Full Text] [Related]  

  • 25. Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label.
    Möhler H; Battersby MK; Richards JG
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1666-70. PubMed ID: 6103538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of benzodiazepine binding to rat brain membranes and solubilized receptor complex by avermectin B1a and gamma-aminobutyric acid.
    Pong SS; Dehaven R; Wang CC
    Biochim Biophys Acta; 1981 Aug; 646(1):143-50. PubMed ID: 6115673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors.
    Blanchard JC; Boireau A; Garret C; Julou L
    Life Sci; 1979 Jun; 24(26):2417-20. PubMed ID: 39209
    [No Abstract]   [Full Text] [Related]  

  • 28. Ontogenetic development of benzodiazepine receptors in the rat brain.
    Braestrup C; Nielsen M
    Brain Res; 1978 May; 147(1):170-3. PubMed ID: 656913
    [No Abstract]   [Full Text] [Related]  

  • 29. Benzodiazepine receptor interactions may be involved in the neurotoxicity of various penicillin derivatives.
    Antoniadis A; Múller WE; Wollert U
    Ann Neurol; 1980 Jul; 8(1):71-3. PubMed ID: 6105838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of proteins irreversibly labeled by 3H-flunitrazepam with different benzodiazepine.
    Sieghart W
    J Neural Transm Suppl; 1983; 18():345-52. PubMed ID: 6135748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative pharmacokinetics of diazepam and flunitrazepam].
    Cano JP; Sumirtapura YC
    Ann Anesthesiol Fr; 1981; 22(2):175-9. PubMed ID: 6115605
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease.
    Messmer K; Reynolds GP
    Neurosci Lett; 1998 Jan; 241(1):53-6. PubMed ID: 9502214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The kinetics and displacement of [11C]flunitrazepam in the brain of the living baboon.
    Comar D; Maziere M; Cepeda C; Godot JM; Menini C; Naquet R
    Eur J Pharmacol; 1981 Oct; 75(1):21-6. PubMed ID: 6119209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of number of benzodiazepine binding sites in the caudate nucleus of the rat after kainic acid injections.
    Sperk G; Schlögl E
    Brain Res; 1979 Jul; 170(3):563-7. PubMed ID: 37987
    [No Abstract]   [Full Text] [Related]  

  • 35. The benzodiazepine receptor in normal and pathological human brain.
    Möhler H; Okada T
    Br J Psychiatry; 1978 Sep; 133():261-8. PubMed ID: 212153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased specific binding of [3H]diazepam in rat brain following chronic diazepam administration.
    DiStefano P; Case KR; Colello GD; Bosmann HB
    Cell Biol Int Rep; 1979 Mar; 3(2):163-7. PubMed ID: 36987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral cation shifts and amino acids in Huntington's disease.
    Gramsbergen JB; Veenma-Van der Duin L; Venema K; Korf J
    Arch Neurol; 1986 Dec; 43(12):1276-81. PubMed ID: 2877650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain-specific benzodiazepine receptors and putative endogenous benzodiazepine-like compounds.
    Paul SM; Marangos PJ; Goodwin FK; Skolnick P
    Biol Psychiatry; 1980 Jun; 15(3):407-28. PubMed ID: 6103718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepines: relationship between pharmacological activity in the rat and in vivo receptor binding.
    Mennini T; Cotecchia S; Caccia S; Garattini S
    Pharmacol Biochem Behav; 1982 Apr; 16(4):529-32. PubMed ID: 6122216
    [No Abstract]   [Full Text] [Related]  

  • 40. No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease.
    Alam ZI; Halliwell B; Jenner P
    J Neurochem; 2000 Aug; 75(2):840-6. PubMed ID: 10899962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.